The Effects of Aplindore on the Treatment of Signs and Symptoms of Parkinson's Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00623324
Recruitment Status : Completed
First Posted : February 26, 2008
Last Update Posted : October 3, 2011
Information provided by (Responsible Party):
Ligand Pharmaceuticals

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : July 2008
  Study Completion Date : No date given